Substrate
Topic

clinical-development

1 stories related to this topic, newest first.

FundaMental Pharma Names Dr. Hans Eriksson Chief Medical Officerrediff.com
business14 hrs ago

FundaMental Pharma Names Dr. Hans Eriksson Chief Medical Officer

FundaMental Pharma GmbH appointed Dr. Hans Eriksson as Chief Medical Officer on June 2, 2026. Eriksson previously led clinical programs at AstraZeneca, Lundbeck, Compass Pathways and HMNC Brain Health.

Benzinga
manilatimes.net
2 sources